GO ID |
Ontology |
GO Term |
Term Definition |
Proteins |
GO:0050776
|
BP
|
regulation of immune response
|
Any process that modulates the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus.
|
TYROBP,
C3,
HLA-B,
COL1A1,
COL3A1,
ITGB2,
ICAM1,
ITGB1,
COL1A2,
FCGR1A,
IFITM1,
HLA-E,
SELL,
PVR,
CD1D,
HLA-G,
VCAM1,
CD33,
KLRC1,
CD40LG,
HLA-A,
HLA-F,
FCGR2B,
BCL6,
CD200,
KIR3DL2,
CD81,
B2M,
CXADR,
SMAD3,
MICB,
MICA,
CD276,
LAIR1,
LAIR2,
LILRB1,
SPPL2A,
CLEC2B,
ULBP3,
TREM1,
COL17A1,
SIGLEC7
|
GO:0050777
|
BP
|
negative regulation of immune response
|
Any process that stops, prevents, or reduces the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus.
|
COL3A1,
AMBP,
LYN,
HLA-G,
TGFB2,
INPP5D,
FOXP3
|
GO:0050778
|
BP
|
positive regulation of immune response
|
Any process that activates or increases the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus.
|
TGFB2
|
GO:0050779
|
BP
|
RNA destabilization
|
Any process that decreases the stability of an RNA molecule, making it more vulnerable to degradative processes.
|
DXO,
TNFRSF1B
|
GO:0050790
|
BP
|
regulation of catalytic activity
|
Any process that modulates the activity of an enzyme.
|
KRIT1,
ZEB2,
BAG2,
CTSB,
AR,
CAPN3,
BRCC3,
RCAN1,
GPSM2,
RING1,
DMPK,
SEPT2,
PPP1R7,
PPP1R3B,
ANKLE2,
GPSM1,
PCP2,
TTN,
MTMR9,
GRPEL1,
GOPC,
BMP2K,
MAT2B,
SH3BP4,
ATP6V1H,
GPSM3
|
GO:0050792
|
BP
|
regulation of viral process
|
Any process that modulates the rate or extent of the viral life cycle, the set of processes by which a virus reproduces and spreads among hosts.
|
CHMP2A,
VPS4B,
CHMP4B
|
GO:0050793
|
BP
|
regulation of developmental process
|
Any process that modulates the frequency, rate or extent of development, the biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote, or a young adult) to a later condition (e.g. a multicellular animal or an aged adult).
|
NOTCH2
|
GO:0050794
|
BP
|
regulation of cellular process
|
Any process that modulates the frequency, rate or extent of a cellular process, any of those that are carried out at the cellular level, but are not necessarily restricted to a single cell. For example, cell communication occurs among more than one cell, but occurs at the cellular level.
|
WNK1
|
GO:0050795
|
BP
|
regulation of behavior
|
Any process that modulates the frequency, rate or extent of behavior, the internally coordinated responses (actions or inactions) of whole living organisms (individuals or groups) to internal or external stimuli.
|
MDK,
HTR2B,
HOXA1,
AHI1
|
GO:0050796
|
BP
|
regulation of insulin secretion
|
Any process that modulates the frequency, rate or extent of the regulated release of insulin.
|
ARNTL,
ENSA,
GCG,
TNF,
IL1B,
SLC25A5,
SLC2A1,
SLC25A4,
CCL5,
PRKCA,
CNR1,
MARCKS,
SSTR5,
LEP,
MTNR1B,
CPT1A,
SNAP25,
RAP1A,
ICA1,
CACNA1C,
ITPR2,
ITPR3,
ITPR1,
KCNJ11,
CACNA1E,
CARTPT,
RAPGEF4,
UQCC2
|
GO:0050798
|
BP
|
activated T cell proliferation
|
The expansion of a T cell population following activation by an antigenic stimulus.
|
FYN,
SATB1
|
GO:0050801
|
BP
|
ion homeostasis
|
Any process involved in the maintenance of an internal steady state of ions within an organism or cell.
|
KLHL3
|
GO:0050803
|
BP
|
regulation of synapse structure or activity
|
Any process that modulates the physical form or the activity of a synapse, the junction between a neuron and a target (neuron, muscle, or secretory cell).
|
APP,
PPT1,
SYNGAP1
|
GO:0050804
|
BP
|
modulation of synaptic transmission
|
Any process that modulates the frequency or amplitude of synaptic transmission, the process of communication from a neuron to a target (neuron, muscle, or secretory cell) across a synapse. Amplitude, in this case, refers to the change in postsynaptic membrane potential due to a single instance of synaptic transmission.
|
CSPG5,
PRKACA,
HRH1,
PPP3CA,
EIF4EBP2,
PXK,
BTBD9
|
GO:0050805
|
BP
|
negative regulation of synaptic transmission
|
Any process that stops, prevents, or reduces the frequency, rate or extent of synaptic transmission, the process of communication from a neuron to a target (neuron, muscle, or secretory cell) across a synapse.
|
PCDH17,
GNAI2,
GNAI1,
ADIPOQ,
TNR
|
GO:0050806
|
BP
|
positive regulation of synaptic transmission
|
Any process that activates or increases the frequency, rate or extent of synaptic transmission, the process of communication from a neuron to a target (neuron, muscle, or secretory cell) across a synapse.
|
CLSTN1,
CCL2,
SYT1,
SLC1A3,
NMU,
DLG4,
KISS1,
CLSTN2,
RETN
|
GO:0050807
|
BP
|
regulation of synapse organization
|
Any process that modulates the physical form of a synapse, the junction between a neuron and a target (neuron, muscle, or secretory cell).
|
DKK1,
IL10,
ETV5
|
GO:0050808
|
BP
|
synapse organization
|
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a synapse, the junction between a neuron and a target (neuron, muscle, or secretory cell).
|
SEMA3E,
PAK3,
CTNNB1,
SNCA,
LRRTM4,
NLGN4X,
SLC9A6,
TNR,
RAB39B,
PCDHGC3,
MYO5A
|
GO:0050810
|
BP
|
regulation of steroid biosynthetic process
|
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of steroids, compounds with a 1,2,cyclopentanoperhydrophenanthrene nucleus.
|
DHH,
TSPO,
LEP,
IGFBP7,
DDX20
|
GO:0050812
|
BP
|
regulation of acyl-CoA biosynthetic process
|
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of acyl-CoA.
|
SNCA
|
GO:0050819
|
BP
|
negative regulation of coagulation
|
Any process that stops, prevents, or reduces the frequency, rate or extent of coagulation.
|
ANXA5,
PROCR
|
GO:0050820
|
BP
|
positive regulation of coagulation
|
Any process that activates or increases the frequency, rate or extent of coagulation.
|
PSEN1
|
GO:0050821
|
BP
|
protein stabilization
|
Any process involved in maintaining the structure and integrity of a protein and preventing it from degradation or aggregation.
|
USP27X,
PLPP3,
SMAD7,
MDM4,
ZNF207,
PARK2,
CREBL2,
USP2,
CRTAP,
WIZ,
APOA1,
GAPDH,
IGF1,
ATP1B1,
PFN1,
HSP90AA1,
HSP90AB1,
HSPA1A,
HSPA1B,
HSPD1,
CLU,
LAMP1,
LAMP2,
CREB1,
TCP1,
FLNA,
PPIB,
MT3,
CALR,
PIK3R1,
PHB,
CDKN1A,
CCT6A,
CCT3,
GNAQ,
CCT8,
ATP1B3,
PTEN,
STXBP1,
UBE2B,
CCT2,
SMAD3,
ANK2,
PRKCD,
SOX4,
EP300,
STK4,
MORC3,
CDC37,
AAK1,
TBRG1,
SYVN1,
USP13,
ZBED3,
PHB2,
CHP1,
CCT7,
PDCD10,
NAA15,
PINK1,
SOX17,
TAF9B,
IFT46,
HPS4,
GTSE1,
NLK,
PPARGC1A,
SEL1L
|
GO:0050829
|
BP
|
defense response to Gram-negative bacterium
|
Reactions triggered in response to the presence of a Gram-negative bacterium that act to protect the cell or organism.
|
TLR4,
TLR5,
LYZL6,
CD4,
APP,
SERPINE1,
IL6,
IL6R,
DEFA4,
HMGB2,
S100A7,
ADM,
SLC11A1,
LYZ,
B2M,
FCN2,
MR1,
OPTN,
PYCARD
|
GO:0050830
|
BP
|
defense response to Gram-positive bacterium
|
Reactions triggered in response to the presence of a Gram-positive bacterium that act to protect the cell or organism.
|
RIPK2,
TLR2,
HIST1H2BK,
LYZL6,
TNF,
CRP,
ANG,
APP,
IL6,
FGR,
MBL2,
DEFA4,
HLA-E,
PLA2G2A,
CD36,
C5AR1,
HMGB2,
IL12A,
ADM,
TIRAP,
LYZ,
B2M,
HIST1H2BC,
ADAM17,
FCN2,
HIST2H2BE,
SEH1L,
PGLYRP2,
TBK1
|
GO:0050832
|
BP
|
defense response to fungus
|
Reactions triggered in response to the presence of a fungus that act to protect the cell or organism.
|
S100A8,
MPO,
S100A9,
DEFA4,
HAMP,
COTL1,
SPON2
|
GO:0050847
|
BP
|
progesterone receptor signaling pathway
|
Any series of molecular signals generated as a consequence of a progesterone binding to its receptor.
|
UBR5,
PHB
|
GO:0050848
|
BP
|
regulation of calcium-mediated signaling
|
Any process that modulates the frequency, rate or extent of calcium-mediated signaling, the process in which a cell uses calcium ions to convert an extracellular signal into a response.
|
GBP1,
RGN
|
GO:0050849
|
BP
|
negative regulation of calcium-mediated signaling
|
Any process that stops, prevents, or reduces the frequency, rate or extent of calcium-mediated signaling.
|
ITPR1
|
GO:0050850
|
BP
|
positive regulation of calcium-mediated signaling
|
Any process that activates or increases the frequency, rate or extent of calcium-mediated signaling.
|
ADA,
CD4,
CCL3,
CCL4,
SYK,
HINT1,
CDH13,
P2RX4
|
GO:0050851
|
BP
|
antigen receptor-mediated signaling pathway
|
A series of molecular signals initiated by the cross-linking of an antigen receptor on a B or T cell.
|
RFTN2
|
GO:0050852
|
BP
|
T cell receptor signaling pathway
|
A series of molecular signals initiated by the cross-linking of an antigen receptor on a T cell.
|
PSMD11,
PSMD12,
PIK3CD,
FYB,
PSMD3,
MAP3K7,
RIPK2,
TNFRSF21,
PSMD10,
PAK3,
BCL10,
CD4,
HLA-DRA,
HLA-DQA2,
HLA-DQA1,
HLA-DQB1,
FYN,
PTPRC,
UBC,
CD28,
HLA-DRB4,
PLCG2,
PSMC3,
NFKB1,
HLA-DPA1,
PSMB1,
PSMA1,
PSMA2,
PSMA3,
PSMA4,
PIK3R1,
PSMB8,
PSMB9,
PSMB4,
PSMB5,
MAPK1,
PSMC2,
PSMB10,
CSK,
PIK3CA,
PIK3CB,
PSMC4,
PSMB3,
PSEN1,
PSMD7,
CACNB3,
PTEN,
PSME3,
PSMC1,
PSMC6,
RPS27A,
UBA52,
SKP1,
HLA-DRB3,
RELA,
PRKCQ,
PDE4D,
PTPRJ,
PAK2,
PSMD2,
UBE2V1,
RFTN1,
PSME4,
SHB,
STK11,
HLA-DRB5,
THEMIS2,
SPPL3,
INPP5D,
PRKD2,
FOXP3,
PAG1,
BTRC
|
GO:0050853
|
BP
|
B cell receptor signaling pathway
|
A series of molecular signals initiated by the cross-linking of an antigen receptor on a B cell.
|
IGLL5,
PIK3CD,
PRKCB,
LYN,
PTPRC,
BCL2,
PLCG2,
MAPK1,
MNDA,
SYK,
MEF2C,
NFATC2,
RFTN1,
KLHL6,
VAV3
|
GO:0050855
|
BP
|
regulation of B cell receptor signaling pathway
|
Any process that modulates the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a B cell.
|
LYN,
PTPN22
|
GO:0050856
|
BP
|
regulation of T cell receptor signaling pathway
|
Any process that modulates the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a T cell.
|
BCL10
|
GO:0050857
|
BP
|
positive regulation of antigen receptor-mediated signaling pathway
|
Any process that activates or increases the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a B- or T cell.
|
PTPRC
|
GO:0050859
|
BP
|
negative regulation of B cell receptor signaling pathway
|
Any process that stops, prevents, or reduces the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a B cell.
|
LPXN,
PLCL2
|
GO:0050860
|
BP
|
negative regulation of T cell receptor signaling pathway
|
Any process that stops, prevents, or reduces the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a T cell.
|
PRNP,
EZR,
PTPN2,
LGALS3,
GBP1,
DUSP3,
PTPRJ,
PAWR,
DUSP22,
PHPT1,
PTPN22
|
GO:0050861
|
BP
|
positive regulation of B cell receptor signaling pathway
|
Any process that activates or increases the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a B cell.
|
PRKCB,
LYN,
CMTM3,
SLC39A10
|
GO:0050862
|
BP
|
positive regulation of T cell receptor signaling pathway
|
Any process that activates or increases the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a T cell.
|
RAB29,
ADA,
PRKD2
|
GO:0050863
|
BP
|
regulation of T cell activation
|
Any process that modulates the frequency, rate or extent of T cell activation.
|
CD4,
CCL5,
PAG1
|
GO:0050865
|
BP
|
regulation of cell activation
|
Any process that modulates the frequency, rate or extent of cell activation, the change in the morphology or behavior of a cell resulting from exposure to an activating factor such as a cellular or soluble ligand.
|
LMO4
|
GO:0050867
|
BP
|
positive regulation of cell activation
|
Any process that activates or increases the frequency, rate or extent of activation.
|
JAK2,
CTGF
|
GO:0050868
|
BP
|
negative regulation of T cell activation
|
Any process that stops, prevents, or reduces the frequency, rate or extent of T cell activation.
|
SOCS6,
LAG3,
DUSP3,
JAK3,
VTCN1,
DUSP22,
PAG1,
PTPN22
|
GO:0050869
|
BP
|
negative regulation of B cell activation
|
Any process that stops, prevents, or reduces the frequency, rate or extent of B cell activation.
|
TNFAIP3,
FAS,
SAMSN1
|
GO:0050870
|
BP
|
positive regulation of T cell activation
|
Any process that activates or increases the frequency, rate or extent of T cell activation.
|
TNFSF11,
MAP3K7,
BCL10,
HSPD1,
CCL2,
HLA-DPA1,
PRKCQ,
CD47,
PYCARD
|
GO:0050871
|
BP
|
positive regulation of B cell activation
|
Any process that activates or increases the frequency, rate or extent of B cell activation.
|
IGLL5,
IL6,
TNFSF4
|
GO:0050872
|
BP
|
white fat cell differentiation
|
The process in which a relatively unspecialized cell acquires specialized features of a white adipocyte, an animal connective tissue cell involved in energy storage. White adipocytes have cytoplasmic lipids arranged in a unique vacuole.
|
SNAI2,
FABP4,
PPARG,
CTBP2,
AACS,
TBL1XR1
|
GO:0050873
|
BP
|
brown fat cell differentiation
|
The process in which a relatively unspecialized cell acquires specialized features of a brown adipocyte, an animal connective tissue cell involved in adaptive thermogenesis. Brown adipocytes contain multiple small droplets of triglycerides and a high number of mitochondria.
|
LRG1,
ADRB2,
ADRB1,
NUDT7,
ADRB3,
SLC2A4,
FABP4,
CEBPB,
ITGA6,
UCP1,
PTGS2,
RGS2,
ALDH6A1,
BNIP3,
ADIPOQ,
MRAP,
ERO1A,
RARRES2,
EBF2,
PPARGC1A
|
GO:0050877
|
BP
|
neurological system process
|
A organ system process carried out by any of the organs or tissues of neurological system.
|
CHRNB1,
KCNJ11,
GPR98
|
GO:0050878
|
BP
|
regulation of body fluid levels
|
Any process that modulates the levels of body fluids.
|
EPHB2,
PDSS2,
HEG1
|
GO:0050880
|
BP
|
regulation of blood vessel size
|
Any process that modulates the size of blood vessels.
|
ITGB1BP1,
NOS3,
NTS,
GCLC,
GCLM,
HBB,
FOXC1
|
GO:0050881
|
BP
|
musculoskeletal movement
|
The movement of an organism or part of an organism using mechanoreceptors, the nervous system, striated muscle and/or the skeletal system.
|
GIGYF2
|
GO:0050882
|
BP
|
voluntary musculoskeletal movement
|
The movement of an organism or part of an organism using mechanoreceptors, the nervous system, striated muscle and/or the skeletal system that can be controlled at will.
|
ITPR1,
HIPK2
|
GO:0050883
|
BP
|
musculoskeletal movement, spinal reflex action
|
Involuntary movement caused by the application of a stimulus to an organism and a subsequent movement. The signal processing of this movement takes place in the spinal cord.
|
ASCL1
|
GO:0050884
|
BP
|
neuromuscular process controlling posture
|
Any process in which an organism voluntarily modulates its posture, the alignment of its anatomical parts.
|
GAA,
TCF15,
PNKD
|
GO:0050885
|
BP
|
neuromuscular process controlling balance
|
Any process that an organism uses to control its balance, the orientation of the organism (or the head of the organism) in relation to the source of gravity. In humans and animals, balance is perceived through visual cues, the labyrinth system of the inner ears and information from skin pressure receptors and muscle and joint receptors.
|
TPP1,
RBFOX2,
NBN,
APP,
GAA,
BCR,
GM2A,
SLC1A3,
ALDH1A3,
RAC3,
DLG4,
ABR,
CLN3,
GIGYF2,
NR4A3,
TNR,
CLIC5,
NRXN1,
CAMTA1
|
GO:0050890
|
BP
|
cognition
|
The operation of the mind by which an organism becomes aware of objects of thought or perception; it includes the mental activities associated with thinking, learning, and memory.
|
SOBP,
CHL1,
HLA-DRA,
LHCGR,
ADORA1,
CHRNA7,
SLC1A4,
HOXA1,
GNAS,
ST3GAL4,
GNAS,
NIPBL,
CYFIP1,
LINS1,
RP9,
PTCHD1,
CHD7,
GTF2A1L,
HRH3
|
GO:0050891
|
BP
|
multicellular organismal water homeostasis
|
Any process involved in the maintenance of an internal steady state of water within a tissue, organ, or a multicellular organism.
|
SCNN1A,
SCNN1G,
TRPV4
|
GO:0050892
|
BP
|
intestinal absorption
|
Any process in which nutrients are taken up from the contents of the intestine.
|
VDR,
CD36,
LEP,
SCARB1,
TJP2,
F11R
|
GO:0050893
|
BP
|
sensory processing
|
Any neural process required for an organism to sense and interpret the dimensions of a sensory experience: modality, location, intensity and affect.
|
TTC8
|
GO:0050896
|
BP
|
response to stimulus
|
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus. The process begins with detection of the stimulus and ends with a change in state or activity or the cell or organism.
|
PDE6D,
MIP,
SCNN1A,
PPT1,
SCNN1G,
TGFBI,
FAM161A,
CYP4V2,
ZNF513,
BBS1,
WDR36,
BBS10,
RPGR,
HPS1,
SPATA7,
SLC45A2
|
GO:0050900
|
BP
|
leukocyte migration
|
The movement of a leukocyte within or between different tissues and organs of the body.
|
ANGPT2,
SLC16A3,
GPR32,
F2,
NRAS,
KRAS,
COL1A1,
FN1,
MMP1,
APOB,
CD74,
ATP1B1,
ITGB3,
ITGB2,
ICAM1,
ITGB1,
FYN,
ITGAV,
LYN,
COL1A2,
SLC3A2,
ITGA5,
CD48,
ITGAM,
SELL,
MIF,
MMP9,
B4GALT1,
CD44,
PECAM1,
SELE,
CD58,
ITGAX,
MAG,
FPR1,
C5AR1,
ITGA6,
FPR2,
ITGA3,
PIK3R1,
MYH9,
BSG,
PIK3CA,
PIK3CB,
ATP1B3,
F2RL1,
JAM2,
PPIA,
GRB2,
CXADR,
SIRPA,
OLR1,
SLC7A9,
SLC7A5,
TEK,
CAV1,
PTPN11,
SOS1,
CD47,
MERTK,
PPIL2,
SELPLG,
GAS6,
GRB14,
ANGPT1,
CD177,
SLC7A6,
INPP5D,
GLG1,
JAM3,
CD244,
TREM1,
SLC7A8,
SLC7A7,
PROCR,
SLC7A11,
F11R
|
GO:0050901
|
BP
|
leukocyte tethering or rolling
|
Transient adhesive interactions between leukocytes and endothelial cells lining blood vessels. Carbohydrates on circulating leukocytes bind selectins on the vessel wall causing the leukocytes to slow down and roll along the inner surface of the vessel wall. During this rolling motion, transitory bonds are formed and broken between selectins and their ligands. Typically the first step in cellular extravasation (the movement of leukocytes out of the circulatory system, towards the site of tissue damage or infection).
|
TNF,
ITGB1,
SELE,
VCAM1,
LEP
|
GO:0050902
|
BP
|
leukocyte adhesive activation
|
The activation of loosely bound or rolling leukocytes by signals displayed on blood vessel endothelial cells, which is typically the second step in cellular extravasation.
|
SELPLG
|
GO:0050904
|
BP
|
diapedesis
|
The passage of a leukocyte between the tight junctions of endothelial cells lining blood vessels, typically the fourth and final step of cellular extravasation.
|
PECAM1
|
GO:0050905
|
BP
|
neuromuscular process
|
Any process pertaining to the functions of the nervous and muscular systems of an organism.
|
UCHL1,
HOXD10,
HOXA1,
FGF12,
KCNA1,
SPG20,
AGTPBP1
|
GO:0050908
|
BP
|
detection of light stimulus involved in visual perception
|
The series of events involved in visual perception in which a light stimulus is received and converted into a molecular signal.
|
GRM6,
BEST1,
EYS
|
GO:0050909
|
BP
|
sensory perception of taste
|
The series of events required for an organism to receive a gustatory stimulus, convert it to a molecular signal, and recognize and characterize the signal. Gustation involves the direct detection of chemical composition, usually through contact with chemoreceptor cells. This is a neurological process.
|
CD36,
SCNN1A,
SCNN1G,
GNB1
|
GO:0050910
|
BP
|
detection of mechanical stimulus involved in sensory perception of sound
|
The series of events involved in the perception of sound vibration in which the vibration is received and converted into a molecular signal.
|
KIT,
COL11A1,
MKKS
|
GO:0050911
|
BP
|
detection of chemical stimulus involved in sensory perception of smell
|
The series of events involved in the perception of smell in which an olfactory chemical stimulus is received and converted into a molecular signal.
|
OR3A3,
OR52E8,
OR5A2,
OR5L2,
OR14C36,
OR2A5,
OR51E2
|
GO:0050913
|
BP
|
sensory perception of bitter taste
|
The series of events required to receive a bitter taste stimulus, convert it to a molecular signal, and recognize and characterize the signal. This is a neurological process.
|
ITPR3
|
GO:0050915
|
BP
|
sensory perception of sour taste
|
The series of events required to receive a sour taste stimulus, convert it to a molecular signal, and recognize and characterize the signal. This is a neurological process.
|
ASIC2,
ASIC3
|
GO:0050916
|
BP
|
sensory perception of sweet taste
|
The series of events required to receive a sweet taste stimulus, convert it to a molecular signal, and recognize and characterize the signal. This is a neurological process.
|
ITPR3
|
GO:0050917
|
BP
|
sensory perception of umami taste
|
The series of events required to receive an umami taste stimulus, convert it to a molecular signal, and recognize and characterize the signal. Umami taste is the savory taste of meats and other foods that are rich in glutamates. This is a neurological process.
|
ITPR3
|
GO:0050918
|
BP
|
positive chemotaxis
|
The directed movement of a motile cell or organism towards a higher concentration of a chemical.
|
NRP1,
PDGFB,
MET,
FGF2,
HMGB1,
SAA1,
SAA2,
CCL3,
BMP4,
CCL5,
SCG2,
MIF,
HGF,
VEGFA,
LGALS3,
FGF7,
HMGB2,
CORO1A,
CXCL12,
VEGFC,
TSC2,
PTPRJ,
SEMA5A,
ALKBH1,
ANGPT1
|
GO:0050919
|
BP
|
negative chemotaxis
|
The directed movement of a motile cell or organism towards a lower concentration of a chemical.
|
SEMA3E,
FLRT2,
SLIT2,
SEMA3D,
APOA1,
PDGFA,
ITGB3,
ITGAV,
PLXNA3,
EFNA5,
RHOA,
SEMA3B,
SEMA5A,
SEMA3A,
SEMA6D,
SEMA3C,
SEMA6A,
SEMA4A,
SEMA6B,
FLRT3
|
GO:0050920
|
BP
|
regulation of chemotaxis
|
Any process that modulates the frequency, rate or extent of the directed movement of a motile cell or organism in response to a specific chemical concentration gradient.
|
PDGFRA,
EFNB2,
CXCR4
|
GO:0050921
|
BP
|
positive regulation of chemotaxis
|
Any process that activates or increases the frequency, rate or extent of the directed movement of a motile cell or organism in response to a specific chemical concentration gradient.
|
PDGFB,
TGFB1,
THBS1,
PDGFRB,
PPM1F,
F2RL1,
STX4,
STX3,
RARRES2
|
GO:0050922
|
BP
|
negative regulation of chemotaxis
|
Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of a motile cell or organism in response to a specific chemical concentration gradient.
|
PTPN2
|
GO:0050925
|
BP
|
negative regulation of negative chemotaxis
|
Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of a motile cell or organism towards a lower concentration in a concentration gradient of a specific chemical.
|
ROBO2
|
GO:0050927
|
BP
|
positive regulation of positive chemotaxis
|
Any process that activates or increases the frequency, rate or extent of the directed movement of a motile cell or organism towards a higher concentration in a concentration gradient of a specific chemical.
|
VEGFA,
ITGA2,
S1PR1,
F2RL1,
CDH13,
SMAD3
|
GO:0050928
|
BP
|
negative regulation of positive chemotaxis
|
Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of a motile cell or organism towards a higher concentration in a concentration gradient of a specific chemical.
|
ANGPT2
|
GO:0050929
|
BP
|
induction of negative chemotaxis
|
Any process that initiates the directed movement of a motile cell or organism towards a lower concentration in a concentration gradient of a specific chemical.
|
SLIT2
|
GO:0050930
|
BP
|
induction of positive chemotaxis
|
Any process that initiates the directed movement of a motile cell or organism towards a higher concentration in a concentration gradient of a specific chemical.
|
CXCL8,
SCG2,
VEGFA,
CXCL12,
PGF,
VEGFC
|
GO:0050942
|
BP
|
positive regulation of pigment cell differentiation
|
Any process that activates or increases the frequency, rate or extent of pigment cell differentiation.
|
BLOC1S6
|
GO:0050951
|
BP
|
sensory perception of temperature stimulus
|
The series of events required for an organism to receive a sensory temperature stimulus, convert it to a molecular signal, and recognize and characterize the signal. This is a neurological process.
|
BTBD9
|
GO:0050953
|
BP
|
sensory perception of light stimulus
|
The series of events required for an organism to receive a sensory light stimulus, convert it to a molecular signal, and recognize and characterize the signal. This is a neurological process.
|
GPR98
|
GO:0050954
|
BP
|
sensory perception of mechanical stimulus
|
The series of events required for an organism to receive a sensory mechanical stimulus, convert it to a molecular signal, and recognize and characterize the signal. This is a neurological process.
|
TRPV1
|
GO:0050955
|
BP
|
thermoception
|
The series of events required for an organism to receive a temperature stimulus, convert it to a molecular signal, and recognize and characterize the signal. Thermoception in larger animals is mainly done in the skin; mammals have at least two types of sensor, for detecting heat (temperatures above body temperature) and cold (temperatures below body temperature).
|
TRPV1
|
GO:0050960
|
BP
|
detection of temperature stimulus involved in thermoception
|
The series of events in which a temperature stimulus is received and converted into a molecular signal as part of thermoception.
|
TRPV1
|
GO:0050965
|
BP
|
detection of temperature stimulus involved in sensory perception of pain
|
The series of events involved in the perception of pain in which a temperature stimulus is received and converted into a molecular signal.
|
NTRK1,
ADORA1,
EPHB1,
TRPV1,
LXN,
ASIC3,
MMP24
|
GO:0050966
|
BP
|
detection of mechanical stimulus involved in sensory perception of pain
|
The series of events involved in the perception of pain in which a mechanical stimulus is received and converted into a molecular signal.
|
NTRK1,
FYN,
ITGA2,
KCNA1,
ASIC3
|
GO:0050968
|
BP
|
detection of chemical stimulus involved in sensory perception of pain
|
The series of events involved in the perception of pain in which a chemical stimulus is received and converted into a molecular signal.
|
TRPV1,
ASIC3
|
GO:0050974
|
BP
|
detection of mechanical stimulus involved in sensory perception
|
The series of events in which a mechanical stimulus is received and converted into a molecular signal as part of sensory perception.
|
SERPINE2,
ASIC2
|
GO:0050976
|
BP
|
detection of mechanical stimulus involved in sensory perception of touch
|
The series of events involved in the perception of touch in which a mechanical stimulus is received and converted into a molecular signal.
|
KCNA1
|
GO:0050982
|
BP
|
detection of mechanical stimulus
|
The series of events by which a mechanical stimulus is received and converted into a molecular signal.
|
JUP,
PKD1,
PKD2,
DENND5A,
DENND5B
|
GO:0050983
|
BP
|
deoxyhypusine biosynthetic process from spermidine
|
The chemical reactions resulting in the formation of deoxyhypusine from spermidine by the enzyme [eIF-5A]-deoxyhypusine synthase. The reaction occurs in four steps: 1. spermidine + NAD+ = dehydrospermidine + NADH + H+; 2. dehydrospermidine + [enzyme]-lysine = 1,3-diaminopropane + [enzyme]-lysine-N6=CH(CH2)3NH2; 3. [enzyme]-lysine-N6=CH(CH2)3NH2 = [eIF-5A]-lysine-N6=CH(CH2)3NH2; 4. [eIF-5A]-lysine-N6=CH(CH2)3NH2 + NADH + H+ = [eIF-5A]-deoxyhypusine + NAD+.
|
DHPS
|
GO:0050992
|
BP
|
dimethylallyl diphosphate biosynthetic process
|
The chemical reactions and pathways resulting in the formation of dimethylallyl diphosphate.
|
IDI1,
IDI2
|
GO:0050994
|
BP
|
regulation of lipid catabolic process
|
Any process that modulates the frequency, rate, or extent of the chemical reactions and pathways resulting in the breakdown of lipids.
|
THRA,
LGALS12,
RARRES2
|